Staging of Neurofibrillary Pathology in Alzheimer's Disease: A Study of the BrainNet Europe Consortium
Irina Alafuzoff(Uppsala University Hospital), Hans Kretzschmar(Ludwig-Maximilians-Universität München), Kelly Del‐Tredici(Institute of Neuroimmunology of the Slovak Academy of Sciences), David Meyronet(Université Claude Bernard Lyon 1), Safa Al‐Sarraj(King's College Hospital), Gábor G. Kovács(Medical University of Vienna), Sergey Larionov(University of Bonn), Heiko Braak(Helmholtz-Institute Ulm), Penelope Korkolopoulou(National and Kapodistrian University of Athens), Dietmar Rudolf Thal(Allen Institute for Brain Science), Piero Parchi(Institute of Neurological Sciences), Giorgio Giaccone(Fondazione IRCCS Istituto Neurologico Carlo Besta), Paul G. Ince(University of Sheffield), Christine Stadelmann(Universitätsmedizin Göttingen), Danielle Seilhean(Inserm), Orso Bugiani(Fondazione IRCCS Istituto Neurologico Carlo Besta), István Bódi(King's College Hospital NHS Foundation Trust), Ellen Gelpí(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Nathalie Streichenberger(Université Claude Bernard Lyon 1), Stephen B. Wharton(University of Sheffield), Andrew King(King's College - North Carolina), Wolfgang Roggendorf(University of Würzburg), Nenad Bogdanović(Karolinska Institutet), Wouter Kamphorst(Vrije Universiteit Amsterdam), Thomas Arzberger(Ludwig-Maximilians-Universität München), Manuel B. Graeber(MIND Research Institute), Efstratios Patsouris(National and Kapodistrian University of Athens), Fabrizio Tagliavini(Fondazione IRCCS Istituto Neurologico Carlo Besta), Camelia Monoranu(University of Würzburg), Isidró Ferrer(Bellvitge University Hospital)
Cited by 479
Related Papers
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
|Neurology|2002|3.5k
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
|Journal of Neuropathology & Experimental Neurology|2011|2.3k